U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Approvals and Databases
  5. Inactive Ingredients in Approved Drug Products Search: Frequently Asked Questions
  1. Drug Approvals and Databases

Inactive Ingredients in Approved Drug Products Search: Frequently Asked Questions

About the Inactive Ingredient Database 

  1. What is an inactive ingredient?
  2. What is an active ingredient?
  3. What is the purpose of the Inactive Ingredient Database?
  4. How do I use the Inactive Ingredient Database?
  5. What is maximum potency?
  6. What is maximum daily exposure (MDE)?
  7. Can an inactive ingredient ever be considered an active ingredient?
  8. Does the Inactive Ingredient Database include contaminants found in approved drug products?
  9. What is a CAS Number?
  10. What is a UNII?
  11. How often do you update the Inactive Ingredient Database?
  12. How can I get a copy of the Inactive Ingredient Database?

 1. What is an inactive ingredient?

According to 21 CFR 210.3(b)(8), an inactive ingredient is any component of a drug product other than the active ingredient. Only inactive ingredients in the final dosage forms of drug products are in this database.

back to top

2. What is an active ingredient?

According to 21 CFR 210.3(b)(7), an active ingredient is any component of a drug product intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect the structure or any function of the body of humans or other animals. Active ingredients include those components of the product that may undergo chemical change during the manufacture of the drug product and be present in the drug product in a modified form intended to furnish the specified activity or effect.

back to top

3. What is the purpose of the Inactive Ingredient Database?

The Inactive Ingredient Database provides information on inactive ingredients present in FDA-approved drug products. This information can be used by industry as an aid in developing drug products. For new drug development purposes, once an inactive ingredient has appeared in an approved drug product for a particular route of administration, the inactive ingredient is not considered new and may require a less extensive review the next time it is included in a new drug product. For example, if a particular inactive ingredient has been approved in a certain dosage form at a certain potency, a sponsor could consider it safe for use in a similar manner for a similar type of product.

back to top

4. How do you use the Inactive Ingredient Database?

You can search the Inactive Ingredient Database by entering any portion of the name of an inactive ingredient. You must enter at least three characters. Search results are displayed alphabetically, sorted first by ingredient, then by the route of administration and dosage form. Routes of administration and dosage forms are derived from current approved labeling.

Field Descriptions

back to top

5. What is maximum potency?

Maximum potency is the highest unit dose amount of the excipient used in approved products that are the basis for the IID listing. The IID lists the highest amount of the excipient per unit dose in each dosage form in which it is used. The amounts shown for maximum potency do not reflect the maximum daily exposure (MDE) or maximum daily intake (MDI) of the excipient unless the maximum daily dose of products that are the basis for the listing is only a single unit. For topical products and other products where excipients are expressed as a percentage of the product formula, maximum potency is the highest formula percentage. Maximum potency of an excipient is a dynamic value that changes when FDA approves products with new, higher levels of the excipient.

 6. What is maximum daily exposure?
 
Maximum daily exposure (MDE) is the total amount of the excipient that would be taken or used in a day based on the maximum daily dose (MDD) of the drug products in which it is used. MDE is calculated as the dosage unit level of the excipient multiplied by the maximum number of dosage units recommended per day (excipient (mg) x number units). MDE may also be referred to as maximum daily intake (MDI) for oral drug products. MDE for a particular IID record (i.e., excipient-route of administration-dosage form combination) may change from publication to publication as FDA gathers data on approved drug products. Our Question & Answer webpage provides additional information about display of MDE in the IID.

7. Can an inactive ingredient ever be considered an active ingredient?

the definition of an active ingredient given in 21 CFR 210.3(b)(7). Alcohol is a good example of an ingredient that may be considered either active or inactive depending on the product formulation.The Inactive Ingredient Database contains inactive ingredients specifically intended as such by the manufacturer. Inactive ingredients can also be considered active ingredients under certain circumstances, according to

Reactants in radiopharmaceutical kits, or inactive ingredients that physically or chemically combine with active ingredients to facilitate drug transport are considered inactive ingredients.

back to top

8. Does the Inactive Ingredient Database include contaminants found in approved drug products?

No. The Inactive Ingredients Database does not include contaminants found in approved drug products.

back to top

9. What is a CAS Number?

The acronym "CAS" stands for "Chemical Abstracts Service," a division of the American Chemical Society that provides comprehensive electronic chemical information services.  CAS assigns unique CAS Registry Numbers to chemical substances. Many inactive ingredients have CAS Registry Numbers, which are useful in searching other databases for chemical information. The CAS Registry Number itself has no chemical significance.

back to top

10. What is a UNII?

The acronym “UNII” stands for “Unique Ingredient Identifier”. The UNII is a part of the joint United States Pharmacopeia (USP)/FDA Substance Registration System (SRS), which has been designed to support health information technology initiatives by providing unique identifiers for substances in drugs, biologics, foods, and devices based on molecular structure and/or descriptive information. The SRS is used to generate permanent, unique, unambiguous identifiers for substances in regulated products, such as ingredients in drug products. The UNII is being displayed in association with inactive ingredients to facilitate Structured Product Labeling (SPL), which requires that a UNII be used for all ingredients, including inactive ingredients.

Not all inactive ingredients will have a UNII. In order to receive a UNII, an ingredient must be a ‘substance’, which is defined as “Any physical material that has a discrete existence, irrespective of origin.” Products will not be assigned a UNII. For example, “purified water” and “sterile water for injection” are considered products within the context of the SRS because something is done to the substance “water” in order to make it more useful. Proprietary ingredients, such as “OPADRY II 85F10919 BLUE”, are considered products and will not be assigned a UNII. Such products are denoted by "N/A".

More information about the UNII and the SRS is available at Substance Registration System - Unique Ingredient Identifier (UNII). All chemically-related questions about the UNII or the SRS that are not answered on the FDA website should be directed fda-srs@fda.hhs.gov

back to top

11. How often do you update the Inactive Ingredient Database?

We update the database quarterly, by the tenth working day of April, July, October, and January.

back to top

12. How can I get a copy of the Inactive Ingredient Database?

You can download the contents of the Inactive Ingredient Database. The Inactive Ingredient Database Download are provided as delimited text and Excel files. 

Text files since 2009 are provided in order to track previous changes.

Data field descriptions
 

back to top

Inactive Ingredient Database Help and Information files

Inactive Ingredient
An inactive ingredient is any component of a drug product other than the active ingredient. Only inactive ingredients in the final dosage forms of drug products are included in this database.

Route and Dosage Form
A route of administration is a way of administering a drug to a site in a patient.   A comprehensive list of specific routes of administration can be found on the FDA Structured Product Labeling (SPL) web page under terminology.

A dosage form is a form in which a drug is produced and dispensed.  A comprehensive list of specific dosage forms can be found on the Structured Product Labeling (SPL) web page under terminology.

CAS Number
The acronym "CAS" stands for "Chemical Abstracts Service," a division of the American Chemical Society that provides comprehensive electronic chemical information services.  CAS assigns unique CAS Registry Numbers to chemical substances.

UNII
The acronym “UNII” stands for “Unique Ingredient Identifier.”
The UNII is a part of the joint USP/FDA Substance Registration System (SRS), which has been designed to support health information technology initiatives by providing unique identifiers for substances in drugs, biologics, foods, and devices based on molecular structure and/or descriptive information. The SRS is used to generate permanent, unique, unambiguous identifiers for substances in regulated products, such as ingredients in drug products.

More information about the UNII and the SRS is available on the Data Council SRS page. All chemically-related questions about the UNII or the SRS that are not answered on the FDA website should be directed fda-srs@fda.hhs.gov.

Potency per Unit Dose
The "potency amount" field specifies the maximum amount of inactive ingredient for each route/dosage form containing that ingredient. When there is no calculable potency measurement for the inactive ingredient, the "potency amount" field will display ‘NA.’

Maximum Daily Exposure
Maximum daily exposure (MDE) is the total amount of the excipient that would be taken or used in a day based on the maximum daily dose (MDD) of the drug products in which it is used. MDE is calculated as the dosage unit level of the excipient multiplied by the maximum number of dosage units recommended per day (excipient (mg) x number units). MDE may also be referred to as maximum daily intake (MDI) for oral drug products.

Resources For You

 
Back to Top